Covered recipient · General Payments record
COURTNEY NICHOLE DAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$692.82
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $651.60 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $184.25 | 3 |
| ABBVIE INC. | $159.09 | 6 |
| Novo Nordisk AS | $133.26 | 2 |
| Axsome Therapeutics, Inc. | $94.02 | 1 |
| Vanda Pharmaceuticals Inc. | $37.17 | 2 |
| Lilly USA, LLC | $27.19 | 1 |
| GlaxoSmithKline, LLC. | $16.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.16 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991586 | CMS |
| ABBVIE INC. | $4.28 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991588 | CMS |
| ABBVIE INC. | $118.07 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991590 | CMS |
| ABBVIE INC. | $4.70 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991592 | CMS |
| ABBVIE INC. | $5.29 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991594 | CMS |
| ABBVIE INC. | $7.59 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106991596 | CMS |
| AstraZeneca Pharmaceuticals LP | $42.69 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104703559 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105554482 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.56 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105396510 | CMS |
| Axsome Therapeutics, Inc. | $94.02 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148350186 | CMS |
| GlaxoSmithKline, LLC. | $16.62 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116018354 | CMS |
| Lilly USA, LLC | $27.19 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135595152 | CMS |
| Novo Nordisk Inc | $116.18 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100348822 | CMS |
| Novo Nordisk Inc | $17.08 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634533 | CMS |
| Vanda Pharmaceuticals Inc. | $17.79 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133938594 | CMS |
| Vanda Pharmaceuticals Inc. | $19.38 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133938596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.